Thank you for visiting us at the
AAOS 2019 Annual Meeting!

In case you missed us, check out the meeting highlights below…

Share on facebook
Share on google
Share on twitter
Share on linkedin

Myoscience participated at the world’s largest orthopaedic meeting in Las Vegas on March 12 -15. The company hosted a number of meeting and non-meeting related activities and showcased its newest products, iovera° Smart Tip 309mm and Smart Tip 190mm.

iovera° Paper Presentation

Preliminary results of iovera’s most recent study was presented by lead investigator William Mihalko, M.D., Ph.D., orthopedic surgeon at Campbell Clinic Orthopaedics in Memphis, TN on Tuesday afternoon. The presentation was well received and the Q&A session was centered around how to integrate the iovera° system into their practice.

AAOS 19 - William Mihalko, M.D., Ph.D - iovera° Paper Presentation

“Cryoneurolysis with the iovera° system has made a measurable impact on pain relief, reduced patients’ use of opioids after surgery and improved overall knee function. I am seeing my patients recover more quickly, with less pain. We are confident the progress demonstrated by the positive preliminary data presented today is a strong indication for the final results of this clinical trial.”

William Mihalko, M.D., Ph.D.
Orthopedic Surgeon at Campbell Clinic Orthopaedics
Timothy I. Still, President and CEO of Myoscience

“These data mark important progress in establishing iovera° therapy as a clinically-validated alternative to opioids for patients recovering from total knee replacement. This trial represents our commitment to developing innovative technologies that offer a safe and reliable option for people suffering from chronic knee pain. We are grateful to Campbell Clinic Orthopaedics for leading this effort and making this trial possible.”

Timothy I. Still
President and CEO of Myoscience

Innovation Theater

Cryoanalgesia: A Path to an Opioid-Free TKA, Pre-op Through Rehab

Myoscience was one of the select companies that presented at the Innovation Theater in the exhibit hall on Wednesday afternoon. Once again, lead Investigator, William Mihalko, MD, presented the preliminary results of the trial, demonstrating that iovera° therapy significantly reduced the use of opioids following total knee arthroplasty (TKA) surgery and significantly reduced pain. The presentation was well-received, with standing-room only during the theater.

iovera at the AAOS Annual Meeting

The Myoscience Booth

stopping pain... cold

Myoscience exhibited in a 20×20 island booth that was divided into four stations (clinical, sales, ultrasound, and a meeting space) to better capture and engage visitors. The booth was co-branded with the iovera° and Myoscience logos and focused on the newest products: Smart Tip 309 and Smart Tip 190.

Ultrasound Corner

Joshua Urban, MD

Each day of the exhibition, Joshua Urban, MD, Orthopaedic Surgeon at OrthoNebraska, hosted education and training sessions regarding how to effectively use ultrasound to locate the genicular nerves (of the knee) to more efficiently perform an iovera° treatment. Dr. Urban’s contributions were incredibly well-received, and we are grateful for his participation at AAOS

AAOS 2019 - Ultrasound Corner

iovera° Experts at the Booth

Special thanks to Joshua Urban, MD; Vinod Dasa, MD; Nirav Amin, MD; Scott Sigman, MD; and William Mihalko, MD for taking the time to answer questions from their peers at the Myoscience booth during the exhibition!


Joshua Urban, MD

Vinod Dasa, MD

dr amin

Nirav Amin, MD

Scott Sigman, MD

Surgeon Reception

Chill out with colleagues at the iovera° Cocktail Reception

Myoscience hosted a surgeon reception located just a few steps away from the Sands Expo where dozens of physicians and partners spent an evening of casual conversation. This was a great opportunity to collaborate, network, and cultivate our partnerships.
AAOS 2019 - Physician Reception

Interested in Learning More?

Your Solution for Opioid-Sparing Surgeries

Less Pain, Fewer Opioids

The iovera° system is a novel, long-lasting nerve block for perioperative and chronic pain. By applying intense cold to targeted nerves, the iovera° therapy prevents pain signals from being transmitted to the brain.
1Radnovich, R et al. “Cryoneurolysis to treat the pain and symptoms of knee OA: a multicenter, randomized, double-blind, sham controlled trial.” Osteoarthritis and Cartilage 25 (2017) 1247-1256.